Drug intelligence / Profile preview

Lactoangin Baby

Development stage: Unknown
Lead developer: IBSS Biomed
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Topical

Overview

Lactoangin Baby is an over-the-counter (OTC) oral spray developed by IBSS Biomed for the supportive treatment of throat and oral cavity infections in children aged 1 year and older. The formulation contains a concentrated supernatant of metabolites (postbiotics) produced by lactic acid bacteria of the *Lactobacillus* genus. These metabolites, including organic acids and bacteriocins, exhibit antimicrobial properties against pathogens such as *Streptococcus pyogenes*, *Staphylococcus aureus*, and *Candida albicans*. By creating an unfavorable environment for pathogenic colonization and helping to restore the natural microbiological balance of the throat, Lactoangin Baby alleviates symptoms of inflammation, pharyngitis, and tonsillitis.

Brand names: Lactoangin Baby

Beyond the preview

Go deeper on Lactoangin Baby.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactoangin Baby.

Explore the full profile